“N-of-One helps my team work more efficiently. I’m confident that the report I’m signing out has only the most relevant treatment options available for the patient, backed by the latest clinical evidence available and reviewed by a team of scientists and oncologists.”
— Carlo Bifulco, MD, Medical Director of Oncological Pathology and Pathology Informatics, Providence Healthcare
N-of-One’s clinical interpretation solutions deliver concise clinical and scientific evidence for each patient case in the context of the cancer sub-type along with the most relevant list of treatment options.
|Actionable. N-of-One expert-powered clinical interpretation empowers oncologists to make informed treatment decisions for each patient.|
|Scalable. N-of-One can interpret any size panel on any testing platform and integrate with any bioinformatics solution for fast turnaround times.|
|Expert. N-of-One’s team of PhD scientists and oncologists ensures that the most advanced clinical and scientific evidence available is analyzed to provide the most relevant treatment strategies, inclusive of molecularly and geographically relevant clinical trials.|
|Comprehensive. N-of-One clinical interpretation looks at the big picture. Whether for a solid tumor, liquid biopsy, or heme panel, we employ multivariant analysis to identify potential interactions with drug sensitivity, resistance, or implications.|
|Advanced. Includes up-to-date clinical trial options matched based on molecular eligibility, as well as clinical and geographic specificity.|